These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications. Schwartz JC; Gros C; Lecomte JM; Bralet J Life Sci; 1990; 47(15):1279-97. PubMed ID: 2146457 [TBL] [Abstract][Full Text] [Related]
3. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543 [TBL] [Abstract][Full Text] [Related]
4. The role of neutral endopeptidase in dogs with evolving congestive heart failure. Margulies KB; Barclay PL; Burnett JC Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362 [TBL] [Abstract][Full Text] [Related]
5. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Danilewicz JC; Barclay PL; Barnish IT; Brown D; Campbell SF; James K; Samuels GM; Terrett NK; Wythes MJ Biochem Biophys Res Commun; 1989 Oct; 164(1):58-65. PubMed ID: 2529858 [TBL] [Abstract][Full Text] [Related]
6. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide. Legault L; Cernacek P; Levy M; Maher E; Farber D J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299 [TBL] [Abstract][Full Text] [Related]
7. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917 [TBL] [Abstract][Full Text] [Related]
12. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871 [TBL] [Abstract][Full Text] [Related]
13. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension. Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168 [TBL] [Abstract][Full Text] [Related]